Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept in systemic lupus erythematosus (ADDRESS II)
NCT01972568Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Dec 2013
- Primary completion
- Apr 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 18
01
Overview
A Phase 2 trial of atacicept in systemic lupus erythematosus (SLE), sponsored by EMD Serono. Started Dec 2013; status: completed.
02
Drugs
atacicept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01972568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972568.